Indegene Wins Frost and Sullivan Award for Pharma AI
Indegene has secured Frost & Sullivan's 2026 Global Enabling Technology Leadership award, validating its impact on AI-driven commercialization in pharma.
Category
Search Results for
Latest stories, in-depth analysis & breaking updates
7+
Articles
The Molecular Revolution — How AI is Accelerating Biopharmaceuticals
Developing a single new pharmaceutical drug has traditionally been one of the most inefficient processes in the human economy. It is a multi-decade, multi-billion-dollar endeavor plagued by a 90% fail...
FTC Seeks Contempt Order Against Martin Shkreli Over Stock Trades
Federal regulators and seven states want a judge to hold Martin Shkreli in contempt for allegedly violating a lifetime ban on trading pharmaceutical stocks.
AI Supercharges the Quest for New Medicines
Artificial intelligence is dramatically accelerating the complex process of drug discovery and design, empowering scientists to identify and develop novel therapeutic compounds with unprecedented spee...
Yosemite Venture Firm Targets Cancer with AI-Driven Biotech
Reed Jobs's venture firm, Yosemite, has rapidly expanded its operations, leveraging artificial intelligence to accelerate biotech discoveries, particularly in cancer research. The firm is capitalizing...
Bioprocessing's New Horizon: Biotech Revolutionizes Food and Industrial Sectors Beyond Pharma
Long confined to pharmaceuticals, bioprocessing technology is now rapidly expanding its reach, poised to transform the food production and industrial manufacturing sectors with innovative, sustainable...
Novo Nordisk GitHub Token Leak Exposes Pharmaceutical Software Development Pipeline
Novo Nordisk GitHub Token Leak Exposes Pharmaceutical Software Development Pipeline Pharmaceutical giant Novo Nordisk suffered an embarrassing but potentially serious security incident when ...
